Restoring Health, Redefining GI Care.
Explore the latest updates, research, and clinical insights driving innovation in regenerative gastrointestinal therapy from pediatric Short Bowel Syndrome (SBS) to emerging applications across the GI tract.
NSF Small Business Innovation Research (SBIR) Grant Award
Eclipse Regenesis, developer of the first restorative therapy to address Short Bowel Syndrome (SBS), has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant of $256,000 to develop a minimally-invasive version of its Eclipse XL1 System™ for pediatric and adult patients with Short Bowel Syndrome. Short […]